150 related articles for article (PubMed ID: 24053653)
1. The preclinical discovery and development of ezogabine for the treatment of epilepsy.
Jankovic S; Ilickovic I
Expert Opin Drug Discov; 2013 Nov; 8(11):1429-37. PubMed ID: 24053653
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
Gunthorpe MJ; Large CH; Sankar R
Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
[TBL] [Abstract][Full Text] [Related]
3. Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data.
Orhan G; Wuttke TV; Nies AT; Schwab M; Lerche H
Expert Opin Pharmacother; 2012 Aug; 13(12):1807-16. PubMed ID: 22783830
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
Faulkner MA; Burke RA
Expert Opin Drug Saf; 2013 Nov; 12(6):847-55. PubMed ID: 23883095
[TBL] [Abstract][Full Text] [Related]
6. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
Splinter MY
Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
[TBL] [Abstract][Full Text] [Related]
7. Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.
Owen RT
Drugs Today (Barc); 2010 Nov; 46(11):815-22. PubMed ID: 21225020
[TBL] [Abstract][Full Text] [Related]
8. ACS chemical neuroscience molecule spotlight on Potiga (Ezogabine).
Hopkins CR
ACS Chem Neurosci; 2012 Aug; 3(8):632. PubMed ID: 22896808
[TBL] [Abstract][Full Text] [Related]
9. New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.
Rudzinski LA; Vélez-Ruiz NJ; Gedzelman ER; Mauricio EA; Shih JJ; Karakis I
J Investig Med; 2016 Aug; 64(6):1087-101. PubMed ID: 27252470
[TBL] [Abstract][Full Text] [Related]
10. Ezogabine treatment of childhood absence epilepsy.
Vossler DG; Yilmaz U
Epileptic Disord; 2014 Mar; 16(1):121-4. PubMed ID: 24659629
[TBL] [Abstract][Full Text] [Related]
11. Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine.
Walleigh DJ; Legido A; Valencia I
Pediatr Neurol; 2013 Nov; 49(5):368-9. PubMed ID: 23916860
[TBL] [Abstract][Full Text] [Related]
12. Retigabine for partial onset seizures.
Rheims S; Ryvlin P
Expert Rev Neurother; 2012 May; 12(5):509-17. PubMed ID: 22550979
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
Patsalos PN; Berry DJ
Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Tompson DJ; Crean CS; Reeve R; Berry NS
Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches to anticonvulsant drug discovery.
Miziak B; Chrościńska-Krawczyk M; Błaszczyk B; Radzik I; Czuczwar SJ
Expert Opin Drug Discov; 2013 Nov; 8(11):1415-27. PubMed ID: 24050182
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
Nass RD; Kurth C; Kull A; Graf W; Kasper B; Hamer HM; Strzelczyk A; Elger CE; Steinhoff BJ; Surges R; Rosenow F
Epilepsy Behav; 2016 Mar; 56():54-8. PubMed ID: 26828693
[TBL] [Abstract][Full Text] [Related]
17. [New antiepileptic drugs, and therapeutic considerations].
Szupera Z
Ideggyogy Sz; 2011 Sep; 64(9-10):329-32. PubMed ID: 22059370
[TBL] [Abstract][Full Text] [Related]
18. Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy.
Hatch RJ; Reid CA; Petrou S
Epilepsia; 2014 Apr; 55(4):601-8. PubMed ID: 24605816
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability.
Brodie MJ; French JA; McDonald SA; Lee WJ; Adams B; Scott A; Nohria V; DeRossett S
Epilepsy Res; 2014 Jul; 108(5):989-94. PubMed ID: 24726452
[TBL] [Abstract][Full Text] [Related]
20. Ezogabine (Potiga) for epilepsy.
Med Lett Drugs Ther; 2012 Aug; 54(1397):65-7. PubMed ID: 22907178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
